1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply-Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Development/Innovation Trends

4. Value Added Insights

    4.1. Disease Epidemiology of Coronary Artery Disease (CAD)

    4.2. Regulatory Scenario, by Country

    4.3. Coronary Angiography Volume Analysis

    4.4. Comparative Assessment

    4.5. Reimbursement Scenario

    4.6. Clinical Trials Analysis

    4.7. Technology Roadmap

    4.8. Patient Diagnostics Journey

    4.9. Product Adoption Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global Healthcare Expenditure Outlook

        5.1.2. Global Diagnostic Tools Market Overview

    5.2. Forecast Factors – Relevance & Impact

        5.2.1. Prevalence of Cardiovascular Diseases (CVDs)

        5.2.2. Growing Healthcare Expenditure

        5.2.3. Increasing Market Consolidation Activities in the Cardiology Industry

        5.2.4. Cost Impact

        5.2.5. Increasing Application of Fractional Flow Reserve Computed Tomography

        5.2.6. Improvement Diagnostic Accuracy

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. Global Market Demand Value or Size (US$ Mn) Analysis 2017-2022 and Forecast, 2023–2033

    6.1. Historical Market Value (US$ Mn) Analysis, 2017-2022

    6.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033

        6.2.1. Y-o-Y Growth Trend Analysis

        6.2.2. Absolute $ Opportunity Analysis

7. Global Market Analysis 2017-2022 and Forecast 2023–2033, By Scan

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis By Scan, 2017-2022

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Scan, 2023–2033

        7.3.1. Obstructive CAD

        7.3.2. Non-obstructive CAD

    7.4. Market Attractiveness Analysis By Scan

8. Global Market Analysis 2017-2022 and Forecast 2023–2033, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2022

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023–2033

        8.3.1. Hospitals

        8.3.2. Diagnostic Imaging Centers

        8.3.3. Cardiology Clinics

    8.4. Market Attractiveness Analysis By End User

9. Global Market Analysis 2017-2022 and Forecast 2023–2033, By Region

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2017-2022

    9.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2023–2033

        9.3.1. North America

        9.3.2. Europe

        9.3.3. Japan

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2017-2022 and Forecast 2023–2033

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017-2022

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

        10.3.1. By Country

            10.3.1.1. U.S.

            10.3.1.2. Canada

        10.3.2. By Scan

        10.3.3. By End User

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Scan

        10.4.3. By End User

    10.5. Market Trends

    10.6. Key Market Participants – Intensity Mapping

    10.7. Drivers and Restraints – Impact Analysis

    10.8. Country Level Analysis & Forecast

        10.8.1. U.S. Market Analysis

            10.8.1.1. Introduction

            10.8.1.2. Market Analysis and Forecast by Market Taxonomy

                10.8.1.2.1. By Scan

                10.8.1.2.2. By End User

        10.8.2. Canada Market Analysis

            10.8.2.1. Introduction

            10.8.2.2. Market Analysis and Forecast by Market Taxonomy

                10.8.2.2.1. By Scan

                10.8.2.2.2. By End User

11. Europe Market 2017-2022 and Forecast 2023-2033

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2022

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

        11.3.1. By Country

            11.3.1.1. Germany

            11.3.1.2. U.K

            11.3.1.3. France

            11.3.1.4. Italy

            11.3.1.5. Netherland

            11.3.1.6. Rest of Europe

        11.3.2. By Scan

        11.3.3. By End User

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Scan

        11.4.3. By End User

    11.5. Market Trends

    11.6. Key Market Participants – Intensity Mapping

    11.7. Drivers and Restraints – Impact Analysis

    11.8. Country Level Analysis & Forecast

        11.8.1. Germany Market Analysis

            11.8.1.1. Introduction

            11.8.1.2. Market Analysis and Forecast by Market Taxonomy

                11.8.1.2.1. By Scan

                11.8.1.2.2. By End User

        11.8.2. UK Market Analysis

            11.8.2.1. Introduction

            11.8.2.2. Market Analysis and Forecast by Market Taxonomy

                11.8.2.2.1. By Scan

                11.8.2.2.2. By End User

        11.8.3. France Market Analysis

            11.8.3.1. Introduction

            11.8.3.2. Market Analysis and Forecast by Market Taxonomy

                11.8.3.2.1. By Scan

                11.8.3.2.2. By End User

        11.8.4. Italy Market Analysis

            11.8.4.1. Introduction

            11.8.4.2. Market Analysis and Forecast by Market Taxonomy

                11.8.4.2.1. By Scan

                11.8.4.2.2. By End User

        11.8.5. Netherland Market Analysis

            11.8.5.1. Introduction

            11.8.5.2. Market Analysis and Forecast by Market Taxonomy

                11.8.5.2.1. By Scan

                11.8.5.2.2. By End User

12. Japan Market Analysis 2017-2022 and Forecast 2023–2033

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2022

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033

        12.3.1. By Scan

        12.3.2. By End User

        12.3.3. Market Attractiveness Analysis

        12.3.4. By Scan

        12.3.5. By End User

    12.4. Market Trends

    12.5. Key Market Participants – Intensity Mapping

    12.6. Drivers and Restraints – Impact Analysis

    12.7. Country Level Analysis & Forecast

13. Market Structure Analysis

    13.1. Market Analysis by Tier of Companies

    13.2. Market Share Analysis of Top Players (%)

    13.3. Market Presence Analysis

        13.3.1. By Regional Footprint of Players

        13.3.2. Product Footprint of Players

        13.3.3. Channel Footprint of Players

14. Competition Analysis

    14.1. Competition Dashboard

    14.2. Branding and Promotional Strategies, By Key Players

    14.3. Key Development Analysis

    14.4. Competition Deep Dive

        14.4.1. Heartflow Inc.

            14.4.1.1. Overview

            14.4.1.2. Product Portfolio

            14.4.1.3. Key Financials

            14.4.1.4. SWOT Analysis

            14.4.1.5. Key Developments

            14.4.1.6. Sales Footprint

            14.4.1.7. Strategy Overview

                14.4.1.7.1. Marketing Strategy

                14.4.1.7.2. Product Strategy

                14.4.1.7.3. Channel Strategy

        14.4.2. Abbott Laboratories

            14.4.2.1. Overview

            14.4.2.2. Product Portfolio

            14.4.2.3. Key Financials

            14.4.2.4. SWOT Analysis

            14.4.2.5. Key Developments

            14.4.2.6. Sales Footprint

            14.4.2.7. Strategy Overview

                14.4.2.7.1. Marketing Strategy

                14.4.2.7.2. Product Strategy

                14.4.2.7.3. Channel Strategy

        14.4.3. Boston Scientific Corp.

            14.4.3.1. Overview

            14.4.3.2. Product Portfolio

            14.4.3.3. Key Financials

            14.4.3.4. SWOT Analysis

            14.4.3.5. Key Developments

            14.4.3.6. Sales Footprint

            14.4.3.7. Strategy Overview

                14.4.3.7.1. Marketing Strategy

                14.4.3.7.2. Product Strategy

                14.4.3.7.3. Channel Strategy

        14.4.4. Bracco SpA

            14.4.4.1. Overview

            14.4.4.2. Product Portfolio

            14.4.4.3. Key Financials

            14.4.4.4. SWOT Analysis

            14.4.4.5. Key Developments

            14.4.4.6. Sales Footprint

            14.4.4.7. Strategy Overview

                14.4.4.7.1. Marketing Strategy

                14.4.4.7.2. Product Strategy

                14.4.4.7.3. Channel Strategy

        14.4.5. GE Electric Co.

            14.4.5.1. Overview

            14.4.5.2. Product Portfolio

            14.4.5.3. Key Financials

            14.4.5.4. SWOT Analysis

            14.4.5.5. Key Developments

            14.4.5.6. Sales Footprint

            14.4.5.7. Strategy Overview

                14.4.5.7.1. Marketing Strategy

                14.4.5.7.2. Product Strategy

                14.4.5.7.3. Channel Strategy

        14.4.6. Heartflow Inc.

            14.4.6.1. Overview

            14.4.6.2. Product Portfolio

            14.4.6.3. Key Financials

            14.4.6.4. SWOT Analysis

            14.4.6.5. Key Developments

            14.4.6.6. Sales Footprint

            14.4.6.7. Strategy Overview

                14.4.6.7.1. Marketing Strategy

                14.4.6.7.2. Product Strategy

                14.4.6.7.3. Channel Strategy

        14.4.7. Medtronic PLC

            14.4.7.1. Overview

            14.4.7.2. Product Portfolio

            14.4.7.3. Key Financials

            14.4.7.4. SWOT Analysis

            14.4.7.5. Key Developments

            14.4.7.6. Sales Footprint

            14.4.7.7. Strategy Overview

                14.4.7.7.1. Marketing Strategy

                14.4.7.7.2. Product Strategy

                14.4.7.7.3. Channel Strategy

        14.4.8. Terumo Corporation

            14.4.8.1. Overview

            14.4.8.2. Product Portfolio

            14.4.8.3. Key Financials

            14.4.8.4. SWOT Analysis

            14.4.8.5. Key Developments

            14.4.8.6. Sales Footprint

            14.4.8.7. Strategy Overview

                14.4.8.7.1. Marketing Strategy

                14.4.8.7.2. Product Strategy

                14.4.8.7.3. Channel Strategy

        14.4.9. B. Braun Melsungen AG

            14.4.9.1. Overview

            14.4.9.2. Product Portfolio

            14.4.9.3. Key Financials

            14.4.9.4. SWOT Analysis

            14.4.9.5. Key Developments

            14.4.9.6. Sales Footprint

            14.4.9.7. Strategy Overview

                14.4.9.7.1. Marketing Strategy

                14.4.9.7.2. Product Strategy

                14.4.9.7.3. Channel Strategy

        14.4.10. Siemens AG

            14.4.10.1. Overview

            14.4.10.2. Product Portfolio

            14.4.10.3. Key Financials

            14.4.10.4. SWOT Analysis

            14.4.10.5. Key Developments

            14.4.10.6. Sales Footprint

            14.4.10.7. Strategy Overview

                14.4.10.7.1. Marketing Strategy

                14.4.10.7.2. Product Strategy

                14.4.10.7.3. Channel Strategy

        14.4.11. Koninklijke Philips N.V.

            14.4.11.1. Overview

            14.4.11.2. Product Portfolio

            14.4.11.3. Key Financials

            14.4.11.4. SWOT Analysis

            14.4.11.5. Key Developments

            14.4.11.6. Sales Footprint

            14.4.11.7. Strategy Overview

                14.4.11.7.1. Marketing Strategy

                14.4.11.7.2. Product Strategy

                14.4.11.7.3. Channel Strategy

15. Assumptions and Acronyms Used

16. Research Methodology

Table 01: Global Market Value (US$ Mn) Analysis 2017–2033, By Scan

Table 02: Global Market Value (US$ Mn) Analysis 2017–2033, By End User

Table 03: Global Market Value (US$ Mn) Analysis 2017–2033, By Region

Table 04: North America Market Value (US$ Mn) Analysis 2017–2033, By Country

Table 05: North America Market Value (US$ Mn) Analysis 2017–2033, By Scan

Table 06: North America Market Value (US$ Mn) Analysis 2017–2033, By End User

Table 07: Europe Market Value (US$ Mn) Analysis 2017–2033, By Country

Table 08: Europe Market Value (US$ Mn) Analysis 2017–2033, By Scan

Table 09: Europe Market Value (US$ Mn) Analysis 2017–2033, By End User

Table 10: Japan Market Value (US$ Mn) Analysis 2017–2033, By Country

Table 11: Japan Market Value (US$ Mn) Analysis 2017–2033, By Scan

Table 12: Japan Market Value (US$ Mn) Analysis 2017–2033, By End User

※参考情報 冠血流予備量比コンピューター断層撮影（FFR-CT）は、冠動脈の狭窄が心筋の血流に与える影響を評価するための画像診断技術です。この技術は、非侵襲的に冠動脈の機能を評価する手段として注目されています。 FFR-CTは、コンピューター断層撮影（CT）の画像を基に、冠動脈の狭窄による組織への血流の変化を示すFractional Flow Reserve（FFR）値を計算します。一般的に、FFR値は0から1の範囲で表され、1に近いほど血流が豊富であることを示します。逆に、0.8以下の値は、狭窄が心筋の血流に著しい影響を及ぼしていることを示し、治療が必要である可能性が高いと評価されます。 この技術の大きな利点は、侵襲的な冠動脈造影を行わずに冠動脈の機能的な評価ができることです。これにより、患者に対するリスクを軽減し、迅速な診断を可能にします。FFR-CTは、特に冠動脈病変の有無やその重篤度を判断する際に有用です。また、心筋虚血のリスクの高い患者において、不必要な冠動脈造影を避けるための有効な手段となります。 FFR-CTは、複数の画像処理技術と解析手法を組み合わせて作成されています。まず、CTスキャンで得られた画像を三次元的に再構成し、冠動脈の形状を明確にします。次に、流体力学的モデルを用いて血流をシミュレーションし、狭窄部位における血流の変化を評価します。この過程では、患者の血圧や心拍数などの生理的データも考慮に入れられます。こうした解析によって、狭窄がもたらす機能的影響を正確に把握することができます。 FFR-CTの用途は広範にわたります。主に冠動脈疾患の診断や治療方針の決定に利用されます。狭窄が明らかになった場合、医師はその影響を基に、カテーテル治療やバイパス手術の必要性を判断します。また、FFR-CTは、心血管疾患のリスク評価や予防医学の分野でも重要な役割を果たします。心筋虚血の危険因子を特定し、生活習慣の改善や早期治療へ導く手助けをします。 さらに、FFR-CTに関連する技術として、人工知能（AI）を用いた解析手法の発展があります。AIは、膨大な医療データを学習することで、画像診断の精度を向上させ、新しい疾患のパターンを発見する能力を持っています。これにより、FFR-CTの解析スピードや信頼性が大幅に向上すると期待されています。診断の効率性が高まることで、患者の治療が迅速に行えるようになります。 FFR-CTは、心血管領域における診断技術の進歩を代表するものです。非侵襲的な性質や迅速な結果提供、個別化された評価が可能な点から、ますます多くの医療機関で導入されつつあります。その結果、心筋虚血に対する適切な治療が行いやすくなり、患者の予後改善にも寄与しています。今後もFFR-CTの技術革新が進むことで、より多くの患者に恩恵をもたらすことが期待されています。医学の進歩とともに、FFR-CTの役割はますます重要になるでしょう。

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/